Original Article
Acceptability and feasibility of S-1 plus cisplatin adjuvant chemotherapy for completely resected non-small cell lung cancer: an open-label, single arm, multicenter, phase 2 trial
Shugo Uematsu, Atsushi Sano, Kazutoshi Isobe, Kazuhiro Usui, Jun Matsumoto, Takaharu Kiribayashi, Kiyohaya Obara, Akihiko Kitami, Yoshitaka Murakami, Akira Iyoda
